Format

Send to

Choose Destination
Sci STKE. 2007 Nov 6;2007(411):pe60.

Neurotrophic factors and Parkinson's disease: the emergence of a new player?

Author information

1
Departments of Neurology and Pharmacology, Columbia University, Neurological Institute of New York, Box 204, 710 West 168th Street, New York, NY 10032, USA. wtd3@columbia.edu

Abstract

The administration of neurotrophic factors is a potential approach to the therapy of neurodegenerative disorders such as Parkinson's disease. However, issues relating to compound delivery and potential side effects have limited the clinical application of this treatment strategy. The identification of CDNF and MANF, which constitute a new class of neurotrophic factors active against dopaminergic neurons, may provide new hope for therapeutic approaches to neurodegenerative disorders based on neurotrophic factors or downstream components of their signaling pathways.

PMID:
17986711
DOI:
10.1126/stke.4112007pe60
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center